Allogeneic CD56-positive CD3-negative Natural Killer Cells

A population of allogeneic lymphocytes expressing the CD56 surface antigen and exhibiting a lack of CD3, with immunomodulating activity. Upon infusion of allogeneic CD56-positive CD3-negative natural killer (NK) cells, these cells are able to secrete cytokines and recognize and kill tumor cells as well as virally-infected cells. CD56 is a transmembrane glycoprotein also known as NCAM (Neural Cell Adhesion Molecule). (NCI Thesaurus)

YOU MAY ALSO LIKE

Allogeneic CD4+ Memory Th1-like T Cells/Microparticle-bound Anti-CD3/anti-CD28

A preparation consisting of allogeneic, differentiated Th1-like T cells bound to T cell-stimulating monoclonal antibodies with potential antitumor activity. More specifically, allogeneic…

Allogeneic CD19-specific CAR-modified CD8 Plus Central Memory-derived Virus-specific T Cells

A preparation of allogeneic Epstein-Barr virus (EBV)- and human cytomegalovirus (CMV)-specific CD8+ central memory-derived T effector-lymphocytes that have been genetically modified to…

Allogeneic bone marrow transplantation

A procedure in which a person receives stem cells (cells from which all blood cells develop) from a genetically similar, but not…

Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine

An allogeneic whole cell vaccine, derived from irradiated allogenic tumor cells manipulated to express human B7.1 (CD80 antigen) and human leukocyte antigen…

Allogeneic AML Antigen-expressing Dendritic Cell Vaccine

A cancer vaccine consisting of allogeneic, immortalized dendritic precursor cells derived from a patient with acute myelogenous leukemia (AML), with potential immunostimulatory…

Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes

A population of allogeneic cytotoxic T-lymphocytes (CTLs) specifically reactive to human adenovirus (Ad) with potential immunomodulating and anti-adenoviral activities. Upon immunoprophylactic adoptive…